Boston - American Association for Thoracic Surgery

More documents

Recommendations

Info

89 TH ANNUAL MEETING MAY 9–MAY 13, 2009BOSTON, MASSACHUSETTSlimb ischemia n = 2, mesenteric ischemia n = 1 and respiratory failure n = 2. distaltype I endoleak n = 1, There was no peri operative myocardial infarction, paraplegia,graft migration, graft collapse or aortic rupture.CONCLUSION: Repair of complex thoraco abdominal aneurysms using a hybridtechnique is safe in an elderly and high risk population of patients at short term.Long term data regarding the hybrid techniques remain to be determined.206
AMERICAN ASSOCIATION FOR THORACIC SURGERYT7. High Resolution Analysis of Lung Cancer Stem and ProgenitorCells in Primary Non-Small Cell AdenocarcinomaVera S. Donnenberg, 1 Rodney J. Landreneau, 2* James D. Luketich, 2*Albert D. Donnenberg 11. Surgery, University of Pittsburgh, Pittsburgh, PA, USA; 2. Hillman Cancer Center,Pittsburgh, PA, USAInvited Discussant: Thomas A. D’AmicoOBJECTIVE: Recurrence following initial response to therapy can occur after longintervals suggesting that therapy resistant cells can lay dormant and subsequentlyreactivate. Distinguishing cancer and normal stem cells is important from thestandpoint of therapy. Here we characterize normal and cancer stem/progenitor-likecells in non-small cell adenocarcinomas of the lung (NSCLCA).METHODS: We used multiparameter flow cytometry to examine tissue stem cellmarkers CD44, CD90, CD117, and CD133, and epithelial markers cytokeratin andEpCAM (TACSTD1), on freshly isolated from untreated NSCLCA (15 malignanteffusions, 82 tumor and adjacent far tissue, 65 bone marrows, 4 normal BM,) 0.5 to10 million cells were stained (nucleated cells: DAPI; Hematopoietic: CD45-APC.Cy7, CD14+CD33+glycophorin-PE.Cy5; Adhesion molecule CD44-PE; Epithelial:HEA-APC, intracellular pancytokeratin (CK)-FITC; Stem/Progenitor:CD90-PE.TxRed, CD117-PE.Cy7, CD133-PE).RESULTS: We are able to assign these immunophenotypic profiles: Stem cellswere resting (low light scatter, 2N DNA), cytokeratin negative and either CD90dimor CD117+. The major progenitor population was morphologically complex andCD90 positive. Largely non-overlapping populations of cytokeratin dim CD117+and CD133+ progenitor cells were detected. This complex pattern is retained intactin well differentiated adenocarcinoma, but is deranged in poorly differentiated andmetastatic lung cancer; the most common pattern being overexpression of cytokeratinon stem/progenitor populations. Stem and progenitor cells are 10 to 100 timesmore prevalent in lung tumors than in normal lung. Cytokeratin+ stem/progenitorcells were not detected in bone marrow samples isolated from rib fragmentsobtained during lung resection.CONCLUSION: According to the cancer stem cell paradigm, we hypothesize thatamong the minority of tumor cells capable of propagating a tumor, only thosewhich retain the tissue stem cell properties responsible for self-renewal and selfprotectionwill survive therapy. Of these, cells with a normal stem-like phenotyperemain in a predominantly resting mode, and can be reactivated to cause late recurrentdisease after apparently successful therapy. Therefore it is of great importanceto determine phenotypic differences that distinguish tumor stem cells from normaltissue stem cells, both for differential targeting and for evaluation of clinicalresponses.WEDNESDAYMorning* AATS Member207
Page 1 and 2:
American Associationfor Thoracic Su
Page 3 and 4:
AMERICAN ASSOCIATION FOR THORACIC S
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158: AMERICAN ASSOCIATION FOR THORACIC S
Page 207: AMERICAN ASSOCIATION FOR THORACIC S
Page 227 and 228: AATS FUTURE MEETINGSMay 1-5, 2010Me
show all

Boston - American Association for Thoracic Surgery

Create successful ePaper yourself

Delete template?

Save as template?